doi: 10.1111/j.1365-2141.1967.tb08860.x.
Experiments on the nature of the prothrombin-converting principle: alteration of proaccelerin by thrombin
- PMID: 6075445
- DOI: 10.1111/j.1365-2141.1967.tb08860.x
Item in Clipboard
Experiments on the nature of the prothrombin-converting principle: alteration of proaccelerin by thrombin
Br J Haematol.
1967 Nov.
No abstract available
Similar articles
-
The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.Biochim Biophys Acta. 1978 Feb 1;538(3):521-33. doi: 10.1016/0304-4165(78)90413-0. Biochim Biophys Acta. 1978. PMID: 564211
-
Studies of the conversion mechanism of prothrombin into thrombin.Tohoku J Exp Med. 1974 Nov;114(3):215-25. doi: 10.1620/tjem.114.215. Tohoku J Exp Med. 1974. PMID: 4456684 No abstract available.
-
Two forms of the human prothrombin converting enzyme (active factor X).Proc Soc Exp Biol Med. 1971 Sep;137(4):1262-6. doi: 10.3181/00379727-137-35769. Proc Soc Exp Biol Med. 1971. PMID: 5138452 No abstract available.
-
Blood coagulation.Annu Rev Biochem. 1980;49:765-811. doi: 10.1146/annurev.bi.49.070180.004001. Annu Rev Biochem. 1980. PMID: 6996572 Review. No abstract available.
-
[Prothrombin activation mechanism].Nihon Rinsho. 1974 May 10;32(5):901-9. Nihon Rinsho. 1974. PMID: 4603779 Review. Japanese. No abstract available.
Cited by
-
The anticoagulant effect of chondroitin sulphates isolated from normal and atherosclerotic regions of human aortas.Br J Exp Pathol. 1982 Feb;63(1):82-7. Br J Exp Pathol. 1982. PMID: 6802163 Free PMC article.
-
Amidolytic properties of single-chain activated Hageman factor.Proc Natl Acad Sci U S A. 1979 Mar;76(3):1461-3. doi: 10.1073/pnas.76.3.1461. Proc Natl Acad Sci U S A. 1979. PMID: 286331 Free PMC article.
-
The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.J Exp Med. 1968 Oct 1;128(4):571-93. doi: 10.1084/jem.128.4.571. J Exp Med. 1968. PMID: 5675434 Free PMC article.
-
Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.J Clin Invest. 1974 May;53(5):1308-19. doi: 10.1172/JCI107678. J Clin Invest. 1974. PMID: 4856883 Free PMC article.
-
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.J Exp Med. 1969 Feb 1;129(2):315-31. doi: 10.1084/jem.129.2.315. J Exp Med. 1969. PMID: 4178758 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
